Investor Relations

2017 News Releases

Webcast ImageWebcast
Millendo Therapeutics, Inc. at Oppenheimer 29th Annual Healthcare Conference (Replay)
03/19/19 at 3:55 p.m. ET
Millendo Therapeutics, Inc. at Oppenheimer 29th Annual Healthcare Conference
Tuesday, March 19, 2019 3:55 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012
DateTitle  
12/20/17Millendo Therapeutics Announces Acquisition of Alizé Pharma SAS to Expand Orphan Endocrinology Pipeline
... 
Printer Friendly Version
11/08/17Millendo Therapeutics Announces Positive Topline Phase 2 Results of ATR-­101 in Classic Congenital Adrenal Hyperplasia
... 
Printer Friendly Version
05/17/17Millendo Therapeutics to Present at the UBS Global Healthcare Conference
... 
Printer Friendly Version
05/15/17Millendo Therapeutics Announces MLE4901 Data Presentations at European Congress of Endocrinology and Congress of the European Menopause and Andropause Society
... 
Printer Friendly Version
04/11/17Millendo Therapeutics Appoints Mary Lynne Hedley, Ph.D. and Carole Nuechterlein, J.D. to Board of Directors
... 
Printer Friendly Version
04/03/17Millendo Therapeutics Announces Publication of Positive Phase 2 Data for MLE4901 for the Treatment of Vasomotor Symptoms
... 
Printer Friendly Version
03/28/17Millendo Therapeutics Announces Initiation of Phase 2 Clinical Trial of ATR-101 in Patients with Endogenous Cushing’s Syndrome
... 
Printer Friendly Version
03/23/17Millendo Therapeutics Announces Data Presentations for MLE4901 and ATR-101 at ENDO 2017 and Kisspeptin 2017
... 
Printer Friendly Version
01/03/17Millendo Therapeutics to Present at J.P. Morgan Healthcare Conference
... 
Printer Friendly Version